What is CAR T-Cell Therapy?
CAR T-Cell Therapy, an immunotherapy sometimes called immune effector cell therapy, is a novel therapy that programs a patient’s immune system to recognize and fight cancer. The immune system is responsible for ridding the body of abnormal cells that are foreign (like cancer) or infected. T-lymphocytes (T-Cells) are a type of cell responsible for killing abnormal cells. During the CAR T-Cell treatment process, T-Cells are drawn from a patient's blood and genetically modified to recognize the patient’s cancer cells when reinfused.
Introduction to CAR T-Cell Therapy Overview: Watch this animated video to understand the science, process and benefits of CAR T-Cell Therapy, often called immune effector cell therapy. Many Sarah Cannon Blood Cancer Networks program offer CAR T-Cell options for patients.
What is a Blood and Marrow Transplant?
When diagnosed with blood cancer, treatment options may include a blood or marrow transplant (BMT), also known as a stem cell transplant.
The Sarah Cannon Blood Cancer Network is one of the largest providers of blood and marrow transplants, conducting more than 1,200 transplants annually.
Blood & Marrow Transplant 101: Watch this animated video to understand the process of a blood and marrow, or stem cell, transplant. As a member of the Sarah Cannon Blood Cancer Network, our program has access to a number of quality, infrastructure, training and research resources.
Remember, each transplant experience is unique - no two patients are exactly alike. The pathway may depend on many factors, including:
- Type of transplant
- Overall health
- Disease status
What Should I expect with a Blood and Marrow Transplant?
Watch these videos from Sarah Cannon partner, Be The Match®, to learn more about blood and marrow transplants.
Bone marrow, peripheral blood stem cell (PBSC), and cord blood provide different sources of cells for transplantation.
Why a good Human Leukocyte Antigen (HLA) match is critical.
Engraftment of donated cells is an important recovery milestone.
Graft-Versus-Host Disease (GVHD) is a common side effect of an allogeneic transplant.
About Be The Match®
Be The Match®, a Sarah Cannon partner, has a team dedicated to supporting patients, caregivers, family members and friends, before, during and after a transplant. They offer confidential one-on-one support, financial guidance and free educational resources. Visit BeTheMatch.org/LearnTheBasics to view more videos to help you learn about and prepare for transplant.